Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies

Author： Chen Ding Gallagher Sandra Monson Nancy L. Herbst Ronald Wang Yue

Publisher： MDPI

E-ISSN： 2077-0383|5|12|107-107

ISSN： 2077-0383

Source： Journal of Clinical Medicine, Vol.5, Iss.12, 2016-11, pp. : 107-107

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparison of the Anti-Tumor Effects of a Chimeric versus Murine Anti-CD19 Immunotoxins on Human B Cell Lymphoma and Pre-B Acute Lymphoblastic Leukemia Cell Lines

By Tsai Lydia K. Pop Laurentiu M. Liu Xiaoyun Vitetta Ellen S.

Toxins, Vol. 3, Iss. 4, 2011-04 ,pp. : 409-419

MDPI

Access to resources Recommend Favorite

Histone Posttranslational Modifications of CD4⁺ T Cell in Autoimmune Diseases

By Wang Zijun Yin Heng Lau Chak Sing Lu Qianjin

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-09 ,pp. : 1547-1547

MDPI

Access to resources Recommend Favorite

The Inflammatory Role of Platelets: Translational Insights from Experimental Studies of Autoimmune Disorders

By Pankratz Susann Bittner Stefan Kehrel Beate E. Langer Harald F. Kleinschnitz Christoph Meuth Sven G. Göbel Kerstin

International Journal of Molecular Sciences, Vol. 17, Iss. 10, 2016-10 ,pp. : 1723-1723

MDPI

Access to resources Recommend Favorite

Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases

By Giacoppo Sabrina Mandolino Giuseppe Galuppo Maria Bramanti Placido Mazzon Emanuela

Molecules, Vol. 19, Iss. 11, 2014-11 ,pp. : 18781-18816

MDPI

Access to resources Recommend Favorite

Drug Therapy in Stroke: From Preclinical to Clinical Studies

Pharmacology, Vol. 92, Iss. 5-6, 2013-12 ,pp. : 324-334

Karger

Access to resources Recommend Favorite